Moderna’s Flu & Covid-19 Combination Vaccine Succeeds in Phase 3 Clinical Trial

Posted
An experimental Moderna combination vaccine for influenza and Covid-19 showed in a pivotal study that it can elicit a higher immune response compared to vaccines that are already available to protect against infection from both viruses. The post Moderna’s Flu & Covid-19 Combination Vaccine Succeeds in Phase 3 Clinical Trial appeared first on MedCity News.

Continue reading at MedCity News »

BioPharma, Daily, Pharma, biopharma nl, Cambridge, Clinical Trials, COVID-19, influenza, Moderna, Vaccines